Patent · US Expired

Isolated peptides which bind to HLA-B18 molecules and uses thereof

US7041502B2 · kind B2 · utility

1Cited by

3References

11Claims

0Family size

Assignee

LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB

Inventors

Janine Bilsborough · Simi Valley, US
Erwin Schultz · Erlangen, DE
Christophe Panichelli · Brussels, BE
Thierry Boon · Brussels, BE
Pierre van der Bruggen · Brussels, BE

Key dates

Filing date	Jun 5, 2002
Grant date	May 9, 2006
Priority date	—
Expiry date	Aug 16, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2239/57
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A peptide, previously identified as a binding partner of HLA-B44, has now been found to bind to HLA-B18 forming a T cell epitope. The therapeutic and diagnostic ramifications of this are the subject of this invention, as are various products obtained in the course of the development of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.